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Colorectal cancer (CRC) is the second most 
prevalent cause of death from cancer in the 
Western world (Lieberman, 2009). One third   
of the 147,000 patients diagnosed with CRC 
every year in the United States will succumb to 
the disease (Lieberman, 2009). Significant prog-
ress has been made in revealing somatic genetic 
alterations in CRC, ranging from the now clas-
sical adenoma–carcinoma sequence to insights 
into genomic instability and patterns of accu-
mulation of somatic mutations at distinct genes 
and loci (Kinzler and Vogelstein, 1996; Cancer 
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Unresolved endoplasmic reticulum (ER) stress in the epithelium can provoke intestinal 
inflammation. Hypomorphic variants of ER stress response mediators, such as X-box–
binding protein 1 (XBP1), confer genetic risk for inflammatory bowel disease. We report 
here that hypomorphic Xbp1 function instructs a multilayered regenerative response in the 
intestinal epithelium. This is characterized by intestinal stem cell (ISC) expansion as shown 
by an inositol-requiring enzyme 1 (Ire1)–mediated increase in Lgr5+ and Olfm4+ ISCs 
and a Stat3-dependent increase in the proliferative output of transit-amplifying cells. 
These consequences of hypomorphic Xbp1 function are associated with an increased pro-
pensity to develop colitis-associated and spontaneous adenomatous polyposis coli (APC)–
related tumors of the intestinal epithelium, which in the latter case is shown to be 
dependent on Ire1. This study reveals an unexpected role for Xbp1 in suppressing tumor 
formation through restraint of a pathway that involves an Ire1- and Stat3-mediated 
regenerative response of the epithelium as a consequence of ER stress. As such, Xbp1 in the 
intestinal epithelium not only regulates local inflammation but at the same time also 
determines the propensity of the epithelium to develop tumors.
© 2013 Niederreiter et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ 
by-nc-sa/3.0/).
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mRNA to spliced Xbp1 (Xbp1s) via its atypical endoribonu-
clease function, which removes 26nt within Xbp1u to gener-
ate an alternate reading frame (Xbp1s; Hetz et al., 2011; Walter 
and Ron, 2011). Unresolved ER stress in IECs has emerged 
as an important mechanism that initiates inflammation in   
the intestine (Kaser et al., 2008). Specifically, partial or com-
plete Xbp1 deletion in mouse IECs leads to unresolved ER 
stress and consequently hypersensitivity of IECs to inflamma-
tory and microbial signals, Paneth cell dysfunction with loss 
of their characteristic granules, increased epithelial apoptosis, 
spontaneous small intestinal enteritis, and increased suscepti-
bility to colitis-inducing agents (Kaser et al., 2008). Fittingly, 
hypomorphic XBP1 variants confer genetic risk for both 
forms of IBD, Crohn’s disease and ulcerative colitis (Kaser   
et al., 2008). Additional genetic risk factors that impact the 
UPR have been discovered in IBD (e.g., ORMDL3 [McGovern 
et al., 2010] and AGR2 [Zheng et al., 2006]), and in some 
cases their genetic deletion in mice can lead to spontaneous 
IBD-like disease as well (Zhao et al., 2010). Notably, it ap-
pears that IECs in IBD generally experience unresolved ER 
stress, even in the absence of overt tissue-destructive inflam-
mation (Heazlewood et al., 2008; Kaser et al., 2008; Tréton   
et al., 2011), with the effectiveness of the UPR being under 
the influence of primary (genetic) and secondary (environ-
mental) factors (Kaser and Blumberg, 2011). Prompted by the 
increased turnover of IECs in mice that lack Xbp1 (Kaser et al., 
2008), here we investigated the UPR’s role in epithelial re-
generation and its implications for intestinal tumorigenesis.
RESULTS
Xbp1 deletion increases ISC numbers
The Xbp1-deficient small intestinal epithelium exhibits in-
creased turnover (Kaser et al., 2008), which is similarly present 
in the colon (Fig. 1, A and B). A 2-h pulse of BrdU revealed 
expansion of the transit-amplifying zone in the ileum and 
colon, whereas a 24-h pulse demonstrated accelerated migra-
tion of IECs along the crypt–villus axis in IEC-conditional 
knockout  Xbp1/(IEC)  mice  compared  with  Xbp1+/+(IEC)  
littermates (Fig. 1, A–C). This corresponded with increased 
numbers of proliferating cell nuclear antigen (PCNA)+ cells 
along the crypt–villus axis in Xbp1/(IEC) mice (Fig. 1, D and 
E). Moreover, deletion of Xbp1 resulted in a 57 ± 3% increase 
in Olfm4+ ISCs (Fig. 1, F and G). This correlated with an   
increased number of BrdU+ cells at the crypt base consistent 
with proliferating ISCs (Fig. 1 H). In situ hybridization (ISH) 
for Lgr5 indicated increased expression in Xbp1/(IEC) com-
pared with Xbp1+/+(IEC), both in the small intestine and colon 
(Fig. 1 I). This was also reflected by a trend toward increased 
Lgr5 mRNA expression in isolated crypts upon quantifica-
tion by RT-PCR (Fig. 1 J) and significantly increased expres-
sion of characteristic mRNAs that define the ISC signature 
(Fig. 1 J; Sato et al., 2011; Muñoz et al., 2012). Altogether, 
these data indicate an expansion of ISC numbers in Xbp1/(IEC) 
compared with Xbp1+/+(IEC) mice. This increase in ISCs is inter-
esting because Paneth cells, which contribute to the ISCs’ niche 
to a variable extent depending on the model system studied 
Genome Atlas Network, 2012). Epidemiological studies sup-
port environmental factors such as obesity as being important 
in the pathogenesis of cancer, including CRC (Calle et al., 
2003; Aggarwal et al., 2009).
CRC arises from the intestinal epithelium, a highly pro-
liferative tissue which renews itself every several days under 
steady-state conditions. Upon intestinal epithelial injury and 
cell loss, such homeostatic renewal is supplanted by a regen-
erative response, which also represents an important defense 
strategy of the host (Amcheslavsky et al., 2009; Cronin et al., 
2009; Jiang et al., 2009). However, an unabated regenerative, 
wound  healing–like  response  to  tissue  injury  may  lay  the 
ground for intestinal tumors (Kuraishy et al., 2011). This is 
clinically evident by the common occurrence of tumors at 
sites of chronic injury (e.g., colitis-associated cancer [CAC] in 
inflammatory bowel disease [IBD] or gastric cancer upon   
Helicobacter pylori infection). Hence, the remarkable paradox 
emerges that cell death caused by tissue injury augments   
the tumorigenic potential of adjoining cells (Kuraishy et al., 
2011). Inflammatory signals from the chronically inflamed 
intestinal microenvironment, such as IL-6 and IL-11 among 
others, have been identified to contribute to such tumor- 
promoting activities in the injured intestine (Becker et al., 2004; 
Bollrath et al., 2009; Grivennikov et al., 2009).
In mammals, the intestinal epithelial compartment con-
sists of several subtypes of differentiated cells (absorptive, Paneth, 
goblet, and enteroendocrine cells) that arise from rapidly   
cycling Lgr5+Olfm4+ intestinal stem cells (ISCs) at the crypt 
bottom (Barker et al., 2007). This Lgr5+ stem cell population 
also gives continuous rise to a quiescent label-retaining popu-
lation, located at the +4 position and expressing Lgr5, that is 
committed to mature into Paneth and enteroendocrine cells, 
but which can alternatively be recalled to the stem cell state 
within the crypt in instances of injury to the crypt (Sangiorgi 
and Capecchi, 2008; Montgomery et al., 2011; Takeda et al., 
2011; Tian et al., 2011; Buczacki et al., 2013; Clevers, 2013). 
ISCs feed into transit-amplifying cells, which serve as the 
forerunners of the differentiated intestinal epithelial cell (IEC) 
types (Barker et al., 2007). Through a model of human spo-
radic and familial CRC, ISCs have been revealed as the cells 
of origin of intestinal cancer (Barker et al., 2009; Zhu et al., 
2009; Schepers et al., 2012).
The unfolded protein response (UPR) is a cytoprotective 
response to ER stress that arises when misfolded proteins   
accumulate in this organelle (Schröder and Kaufman, 2005; 
Todd et al., 2008; Walter and Ron, 2011). In metazoans, three 
core UPR-associated pathways coordinate an adaptive response 
to ER stress that results in expansion of the ER, promotion   
of ER-associated degradation and chaperone functions and, 
when unabated, cellular death by apoptosis. The evolutionarily 
most conserved UPR branch consists of inositol-requiring   
enzyme 1 (Ire1; encoded by Ern1), an ER stress sensor, and 
the transcription factor X-box–binding protein 1 (Xbp1) as its 
effector (Schröder and Kaufman, 2005; Ron and Walter, 2007; 
Todd et al., 2008; Kohno, 2010; Walter and Ron, 2011). Ire1 
activates Xbp1 by conversion of unspliced Xbp1 (Xbp1u) JEM Vol. 210, No. 10 
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Figure 1.  Xbp1 deletion increases ISC numbers. (A) Animals were injected with BrdU and sacrificed 24 h later. BrdU+ cells per total cells along the 
crypt–villus axis were counted (n = 3/4; two-tailed Student’s t test). (B) Anti-BrdU IHC of the ileum and colon 24 h after i.p. injection with BrdU (n = 3/4). 
(C) Similar experiment as A with a 2-h BrdU pulse to assess transit-amplifying cells (n = 4/4; two-tailed Student’s t test). (D) Anti-PCNA IHC of the small 
intestine (n = 5/5). (E) PCNA+ cells per total cells along the crypt–villus axis were counted (n = 5/5; two-tailed Student’s t test). (F) Olfm4+ ISCs (ISH; red 
arrowheads) in the small intestine of Xbp1+/+(IEC) and Xbp1/(IEC) mice. Lysozyme staining identified fully differentiated Paneth cells (black arrowheads) 
intermingled with ISCs (n = 3/4). (G) Quantification of Olfm4+ ISCs per 100 crypts (n = 3/4; two-tailed Student’s t test). (H) Sections of Xbp1+/+(IEC) and 
Xbp1/(IEC) mice from C were analyzed for BrdU+ cells at the crypt bottom up to position +4 (n = 4/4). (I) ISC identification by Lgr5 ISH in ileum and colon 
(Lgr5+ crypts marked by red arrowheads; n = 4/4). Bars: (B, D, and I) 20 µm; (F) 5 µm. (J and K) Analysis of isolated crypt mRNA of Xbp1+/+(IEC) and Xbp1/(IEC) 
mice for transcripts representative of the ISC signature (J; Muñoz et al., 2012) or Paneth cell signature (K; Sato et al., 2011) by RT-pPCR (n = 12/11; Stu-
dent’s t test). Graphs show mean ± SEM. §, P = 0.0548; *, P < 0.05; **, P < 0.01; ***, P < 0.001.2044 Xbp1 controls intestinal tumorigenesis | Niederreiter et al.
Hypomorphic Xbp1 leads to Jak1/Stat3 activation in IECs
In Drosophila melanogaster, injured enterocytes induce cyto-
kines (Upd, Upd2, and Upd3) that activate Jak/Stat (dome, hop, 
and STAT92E) signaling in intestinal epithelial stem cells, 
which promotes their division and initiates progenitor cell 
differentiation (Amcheslavsky et al., 2009; Jiang et al., 2009). 
In the mammalian system, this feedback mechanism that   
links enterocyte loss to stem cell output is less well understood. 
The mammalian orthologues of the Drosophila pathway (IL-6,   
IL-11, and Stat3) play an important role in IEC regeneration 
(Becker et al., 2004; Bollrath et al., 2009; Grivennikov et al., 
2009; Pickert et al., 2009). Fig. 3 A shows substantial levels of 
Stat3 Tyr-705 phosphorylation (p) in the Xbp1/(IEC) epithe-
lium, whereas only minimal p-Stat3 was observed in Xbp1+/+(IEC) 
epithelium. Immunohistochemistry (IHC) localized p-Stat3 
to the transit-amplifying zone with further extension into   
the villus epithelium, with barely any immunoreactivity de-
monstrable within the crypts (Fig. 3 B). Jak1 but not Jak2 
phosphorylation  was  also  induced  in  Xbp1/(IEC)  com-
pared with Xbp1+/+(IEC) epithelium (Fig. 3 A). Total Stat3 as 
well as Jak1 and Jak2 was also increased (Fig. 3 A), which 
might reflect the known capacity of Stat3 to bind its own 
promoter and to transactivate its transcription (Narimatsu   
et al., 2001; Lam et al., 2008; Snyder et al., 2008). Increased   
p-Stat3 was independent of Ire1 as Xbp1/(IEC);Ern1/(IEC) 
and Xbp1/(IEC);Ern1+/+(IEC) epithelia exhibited similar levels 
(Fig. 3 C). These experiments provide evidence for Ire1- 
independent  Stat3  activation  in  Xbp1-deficient  epithelia   
that localizes to the transit-amplifying zone and its down-
stream progeny.
Stat3 blockade abrogates epithelial hyperproliferation  
in Xbp1-deficient epithelium
S3I-201 selectively inhibits Stat3 transcriptional activities by 
blocking dimer formation and DNA binding (Siddiquee et al., 
2007). To test whether Stat3 is responsible for epithelial hyper-
proliferation in Xbp1-deficient IECs, we administered S3I-201 
i.p. every other day for 14 d to Xbp1/(IEC) mice. Fig. 3 D 
demonstrates that Stat3 inhibition abrogated the increased 
turnover of the intestinal epithelium in Xbp1/(IEC) mice. 
Notably, S3I-201 did not affect ISC numbers in Xbp1/(IEC) 
mice (Fig. 3 E), which is consistent with an absence of p-Stat3 
in crypts (Fig. 3 B). Of note, S3I-201 did not affect epithelial 
turnover in Xbp1-sufficient mice (not depicted), indicating 
that this Stat3-dependent mechanism is specifically engaged 
under conditions of ER stress. Altogether, these data establish 
that Xbp1 deficiency results in Stat3 activation in the transit-
amplifying zone, which mediates the hyperproliferation of 
ER-stressed IECs.
Hypomorphic Xbp1 induces an autocrine activation loop  
in IECs via NF-B, IL-6/IL-11, and Stat3
We chose the small IEC line MODE-K as a model system   
for studying the mechanisms underlying Stat3 activation and 
silenced Xbp1 expression via a lentivirus expressing a specific 
shRNA (Kaser et al., 2008). Stable Xbp1 silencing resulted   
in profound Stat3 Tyr-705 phosphorylation compared with 
(Sato et al., 2011; Durand et al., 2012; Kim et al., 2012;  Yilmaz 
et al., 2012), are morphologically condensed to Paneth cell 
remnants  that  lack  their  characteristic  secretory  apparatus 
when Xbp1 is deleted (Kaser et al., 2008). Among the genes that 
had been reported as most highly enriched in Paneth cells 
and that could support a niche function for ISCs are Wnt3, 
Wnt11, Egf, Tgfa, and Dll4 (Sato et al., 2011). Among those, 
we noted a threefold increase in mRNA expression of Wnt11 
in Xbp1/(IEC) compared with Xbp1+/+(IEC) crypts (Fig. 1 K).
ISC expansion is dependent on overactivation of Ire1
The design of the floxed Xbp1 allele results in a premature 
stop codon upon Cre-mediated deletion of exon 2, but it re-
tains the capacity to monitor the splicing status of Xbp1 
mRNA (Kaser et al., 2008). Reduced or absent Xbp1 func-
tion  in  IECs  leads  to  profound  splicing  of  Xbp1  mRNA 
(Kaser et al., 2008), which is consistent with unresolved ER 
stress and indicative of massive Ire1 activation (Hetz et al., 
2011). Indeed, although Ire1 phosphorylation was not de-
tectable in Xbp1+/+(IEC) epithelium, Xbp1 deletion resulted 
in strong Ire1 phosphorylation, along with increased ex-
pression of total protein (Fig. 2 A). To test whether Ire1 is 
involved in ISC activation under ER stress, we generated 
double-conditional VCre;Ern1fl/fl;Xbp1fl/fl mice. Fig. 2 (B and C) 
shows abrogation of the increase in ISC numbers in the   
small intestine of Xbp1/(IEC);Ern1/(IEC) compared with 
Xbp1/(IEC);Ern1+/+(IEC) mice, with Xbp1/(IEC);Ern1+/(IEC) 
mice exhibiting an intermediate phenotype. In contrast, under 
homeostatic conditions in Xbp1-sufficient IECs (Xbp1+/+(IEC)), 
Ire1 did not affect the size of the ISC pool (Fig. 2 D). The 
floxed exons 20 and 21 of the Ern1 allele encode the endori-
bonuclease domain of Ire1, whereas the kinase domain is 
encoded upstream and remains intact (Iwawaki et al., 2009). 
In Ern1/(IEC) mice, a truncated Ire1 protein was detectable 
(Fig. 2 E) that lacked the capacity for massive Xbp1 mRNA 
splicing  in  Xbp1-deficient  IECs  of  double  mutant  mice 
(Fig. 2 F), as expected, and indeed was not phosphorylated 
under ER stress, demonstrating loss of its endoribonuclease 
and kinase activity (Fig. 2 A). In addition to ubiquitously 
expressed Ire1, IECs express another isoform (Ire1) with 
the capacity to splice Xbp1 mRNA (Bertolotti et al., 2001).   
It is therefore remarkable that genetic co-deletion of Ire1 
(Xbp1/(IEC);Ern1/(IEC)) alone was sufficient to completely 
revert the massive splicing of Xbp1 mRNA to the baseline 
levels observed in Xbp1-sufficient IECs (Fig. 2 F). This implies 
that Ire1 is not overactivated in a similar way as is Ire1 as a 
consequence of ER stress caused by Xbp1 deletion. Hence, 
Ire1 drives regenerative ISC expansion upon sensing ER 
stress in the intestinal epithelium, but it is not involved in 
homeostatic ISC regulation. In contrast to ISC expansion, 
Ire1 did not affect the hyperproliferation of the ER-stressed, 
Xbp1-deleted intestinal epithelium (Fig. 2 G). Collectively, 
these data indicate that although hyperproliferation and ISC 
expansion are both consequences of Xbp1 deletion and pre-
sumably ER stress, only the increase in ISC numbers is under 
the control of Ire1.JEM Vol. 210, No. 10 
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Figure 2.  ISC expansion is dependent on overactivation of Ire1. (A) Immunoblot of total and phosphorylated Ire1 of indicated genotypes in 
total epithelial scrapings or after immunoprecipitation (IP) as indicated. Samples were immunoprecipitated with anti-Ire1 pAb H-190 (immunogen: 
amino acids 371–560) and immunoblotted with anti-Ire1 mAb 14C10 (immunogen: C-terminal fragment) or pAb H-190. Data are representative of four 
independent experiments. (B) Sections of the indicated genotypes were in situ hybridized for Olfm4 (red arrowheads), stained for lysozyme (black arrow-
heads), or both (n = 5 per group). Bars, 5 µm. (C) Quantification of Olfm4+ ISCs per 100 crypts (n = 5 per group with combined analysis of duodenum, 
jejunum, and ileum; one-way ANOVA with Bonferroni post-hoc test). (D) Quantification of Olfm4+ ISCs in Ern1+/+(IEC), Ern1+/(IEC), and Ern1/(IEC) mice  
(n = 5 per group). (E) Western blot of Ern1+/+(IEC) and Ern1/(IEC) (exons 20–21 floxed) mice immunoblotted with mAb 14C10 and pAb H-190 detects a 
truncated Ire1 protein in Ern1/(IEC) epithelial scrapings. (F) Xbp1 mRNA splicing in epithelial scrapings of the indicated genotypes. 171 bp, Xbp1u; 145 
bp, Xbp1s. (E and F) Data are representative of two independent experiments. (G) Animals were injected with BrdU and harvested 24 h later to assess epi-
thelial turnover. BrdU+ cells per total cells along the crypt–villus axis were counted (n = 4 per group with combined analysis of duodenum, jejunum, and 
ileum; one-way ANOVA with Bonferroni post-hoc test). Graphs show mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.2046 Xbp1 controls intestinal tumorigenesis | Niederreiter et al.
Figure 3.  Hypomorphic Xbp1 leads to Jak1/Stat3 activation in the intestinal epithelium. (A) Immunoblot for p-Stat3, Stat3, p-Jak1, Jak1, p-Jak2, 
and Jak2 on epithelial colonic scrapings. Data are representative of more than four independent experiments. (B) IHC localizes p-Stat3 immunoreactivity 
to IECs in the transit-amplifying zone and villus, but largely spares the crypt bottom (n = 3/3). Boxed areas are shown at higher magnification on the 
right. Bars, 20 µm. (C) Small intestinal epithelial scrapings from the indicated genotypes were analyzed for p-Stat3, Stat3, p-Jnk, and Jnk. The experiment 
was performed with four mice per group. (D) Mice were treated with the Stat3 inhibitor S3I-201 or vehicle for 14 d, and BrdU was administered 24 h 
before harvest. The ratio of BrdU+ cells per total IECs along the crypt–villus axis in the small intestine is presented (n = 4/5/7; one-way ANOVA with  
Bonferroni post-hoc test). (E) Olfm4+ ISCs counted in the same experiment as in D (n = 2/3/3; one-way ANOVA with Bonferroni post-hoc test). (F) MODE-K.iXbp1 
and MODE-K.iCtrl cells were stimulated with the ER stress inducer tunicamycin and analyzed for Stat3 Tyr-705 phosphorylation. Data are representative 
of two independent experiments. (G) Il6 and Il11 mRNA expression in MODE-K.iXbp1 and MODE-K.iCtrl cells (n = 3; two-sided Student’s t test). Data are 
representative of two independent experiments. (H) Supernatants from MODE-K.iXbp1 and MODE-K.iCtrl cells were analyzed for IL-6 and IL-11 secretion 
by ELISA (n = 6; two-sided Student’s t test). (I) MODE-K.iXbp1 and MODE-K.iCtrl cells were incubated with anti–IL-11 and anti–IL-6 mAbs or respective JEM Vol. 210, No. 10 
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of somatic stem cells in the Drosophila gut. Moreover, Jnk   
can be recruited to Ire1 via the adapter molecule tumor ne-
crosis factor receptor–associated factor 2 (Traf2) under certain 
conditions of ER stress (Urano et al., 2000). To test the hy-
pothesis that Jnk activation may contribute to the Ire1- 
dependent increase in ISC numbers or has a role in determining 
the increased proliferative output of the transit-amplifying 
zone, we administered SP600125 i.p. every other day for   
14 d to Xbp1/(IEC) mice. As depicted in Fig. 3 (M and N), 
SP600125 affected neither Olfm4+ ISC numbers nor IEC 
turnover along the crypt–villus axis. Furthermore, increased 
Jnk phosphorylation in IECs was indistinguishable between 
Xbp1/(IEC);Ern1/(IEC) and Xbp1/(IEC) mice and hence 
not under the control of Ire1 (Fig. 3 C). These observations 
let us conclude that Jnk does not have a critical role in the 
hyperregenerative  phenotype  observed  in  the  ER-stressed, 
Xbp1-deficient intestine.
Xbp1 protects from CAC
Long-standing IBD may lead to CAC, which has served as a 
paradigm for the relationship between inflammation and can-
cer (Grivennikov et al., 2010; Mantovani, 2010; Danese and 
Fiocchi, 2011). The mediators involved in regeneration of   
the ER-stressed, Xbp1-deficient intestinal epithelium, such as 
Stat3, IL-6/IL-11, and NF-B, also cooperate to drive CAC 
(Becker et al., 2004; Greten et al., 2004; Bollrath et al., 2009; 
Grivennikov  et  al.,  2009;  Grivennikov  and  Karin,  2010; 
Kuraishy et al., 2011). We therefore induced CAC by azoxy-
methane (AOM), followed by three cycles of dextran sodium 
sulfate (DSS; Fig. 4 A; Greten et al., 2004). Xbp1/(IEC) mice 
developed >10-fold more and larger colonic tumors compared 
with Xbp1+/+(IEC) littermate controls (Fig. 4, B–D). When ana-
lyzed at an early time point (day 15 after initiation), atypical re-
generative lesions were only detected in Xbp1/(IEC), but not 
in Xbp1+/+(IEC), mice (Fig. 4 E). Similarly, reactive oxygen spe-
cies (ROS) levels were increased fivefold in Xbp1/(IEC) rela-
tive to Xbp1+/+(IEC) epithelia at day 15 (Fig. 4 F), consistent with 
ROS generation in ER-stressed, Xbp1-deficient cells (Liu et al., 
2009) and increased severity of DSS colitis in Xbp1/(IEC) 
mice (Kaser et al., 2008). ROS can lead to DNA damage and 
thereby  contribute  to  cancer  initiation  and  progression   
(Sedelnikova et al., 2010). Indeed, at day 15, Xbp1/(IEC) epi-
thelia exhibited nuclear staining for p53 (Fig. 4 E), evidence 
for a DNA damage response (Brady et al., 2011), together 
with a trend toward an increase in aneuploid cells compared 
control-silenced cells (Fig. 3 F). Stat3 Tyr-705 phosphoryla-
tion was also induced in Xbp1-sufficient MODE-K cells after 
ER stress induction via tunicamycin (Fig. 3 F). The extent   
of Stat3 phosphorylation in Xbp1-silenced MODE-K cells 
was not further augmented by incubation with tunicamycin 
(Fig. 3 F) and, in fact, decreased at the latest time point stud-
ied, likely reflecting the exhaustion of the compensatory 
UPR (Fig. 3 F). These experiments establish that Stat3 activa-
tion in IECs is likely to be an IEC-intrinsic consequence of 
unresolved ER stress.
IL-6 and IL-11 are prototypical Stat3-activating cytokines 
(Yu et al., 2009). Xbp1 silencing induced mRNA expression and 
protein secretion of IL-6 and IL-11 in MODE-K cells (Fig. 3, 
G and H). Neutralization experiments with anti-cytokine   
antibodies revealed that combined administration of anti– 
IL-6 and anti–IL-11 mAbs abrogated increased Stat3 phos-
phorylation in MODE-K.iXbp1 cells (Fig. 3 I). Co-silencing 
of individual cytokine receptor–associated Janus tyrosine ki-
nases (Jak1-3 and Tyk2; Yu et al., 2009) in MODE-K.iXbp1 
cells revealed Jak1 as the critical kinase for Stat3 activation 
under ER stress conditions (Fig. 3 J). These data indicate that 
hypomorphic Xbp1 leads to induction of IL-6 and IL-11   
secretion in IECs, which in turn activates Stat3 phosphoryla-
tion via a Jak1-dependent mechanism.
Il6 is typically transactivated by NF-B (and, e.g., also by 
Stat3; Vallabhapurapu and Karin, 2009; Yu et al., 2009). ER 
stress can lead to NF-B activation via several mechanisms 
(Vallabhapurapu and Karin, 2009). Xbp1/(IEC) IECs exhib-
ited increased total NF-B p65 and p-p65 compared with 
Xbp1+/+(IEC) mice (Fig. 3 K). Blocking NF-B activation in 
Xbp1/(IEC) mice via the specific irreversible inhibitor of 
IB phosphorylation, BAY 11-7082 (Pierce et al., 1997),   
indeed abrogated Stat3 activation to baseline levels observed 
in Xbp1+/+(IEC) littermates (Fig. 3 L). Hence, hypomorphic 
Xbp1 function is associated with increased NF-B–dependent 
activation of Stat3 in IECs.
Jnk inhibition in Xbp1/(IEC) mice does not affect  
ISC expansion or hyperproliferation
Hypomorphic Xbp1 function had previously been reported 
to result in activation of Jnk, and pharmacological blockade   
of Jnk phosphorylation with the specific inhibitor SP600125 
resulted in abrogation of elevated CXCL1 secretion in Xbp1-
deficient IECs (Kaser et al., 2008). Biteau et al. (2008) reported 
that Jnk regulates proliferation and the regenerative capacity 
isotype control antibodies, and Stat3 Tyr-705 phosphorylation was analyzed in cell lysates. Data are representative of three independent experiments. 
(J) MODE-K.iXbp1 and MODE-K.iCtrl cells were co-silenced with Jak1-, Jak2-, Jak3-, and Tyk2-specific or scrambled siRNAs, and Stat3 Tyr-705 phosphory-
lation was analyzed. Data are representative of four independent experiments. (K) IECs of Xbp1+/+(IEC) and Xbp1/(IEC) mice were analyzed for p–NF-B 
p65 and total NF-B p65. Data are representative of two independent experiments. (L) The NF-B inhibitor BAY 11-7082 or vehicle was administered to 
Xbp1+/+(IEC) and Xbp1/(IEC ) mice for 2 wk, and Stat3 Tyr-705 phosphorylation was analyzed in small IEC scrapings. Data are representative of three inde-
pendent experiments. (A, C, F, and I–L) Gapdh was used as a loading control. (M) Mice were treated with the Jnk inhibitor SP600125 or vehicle for 14 d, 
and Olfm4+ ISCs were counted (n = 5/6/7; one-way ANOVA with Bonferroni post-hoc test). (N) The ratio of BrdU+ cells per total IECs along the crypt–
villus axis in the small intestine 24 h after BrdU administration is analyzed in the same experiment as in M (n = 5/6/7; one-way ANOVA with Bonferroni 
post-hoc test). Graphs show mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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et al., 2008), increased tumorigenesis in Xbp1/(IEC) compared 
with Xbp1+/+(IEC) mice in the AOM/DSS model as observed 
here may result from a combination of inflammatory, tumor-
promoting signals emanating from the more intense myeloid 
infiltrate (Greten et al., 2004; Bollrath et al., 2009; Grivennikov 
et al., 2009), as well as from IEC-intrinsic mechanisms.
with Xbp1+/+(IEC) IECs (Fig. 4 G). Moreover, Stat3 phosphory-
lation was increased in Xbp1/(IEC) compared with Xbp1+/+(IEC) 
mice (Fig. 4, H and I). These observations imply that epithelial 
Xbp1 deficiency is associated with a profound increase in tu-
morigenesis in CAC. Because IEC-specific Xbp1 deficiency is 
associated with increased severity of DSS-induced colitis (Kaser 
Figure 4.  Xbp1 suppresses CAC. (A) Schematic overview of the AOM/DSS CAC model. (B) Representative H&E staining of colon of Xbp1+/+(IEC) and 
Xbp1/(IEC) at day 61 of AOM/DSS colitis. Individual tumors are highlighted by red dashed lines (one of three individual experiments; n = 4/3; total n = 
13/10). (C and D) Tumor number (C) and area (D) in Xbp1+/+(IEC) and Xbp1/(IEC) at day 61 of AOM/DSS colitis (one of three individual experiments; n = 4/3; 
total n = 13/10; two-sided Student’s t test). (E, top) Atypical regenerative foci (white dashed lines) identified on H&E stainings on day 15 of AOM/DSS 
colitis. Number of lesions per colon is shown. (bottom) Staining for p53 was analyzed by IHC (arrowheads, p53+ nuclei; HPF, high power field; n = 4/4; 
two-sided Student’s t test). (F) ROS in colonic epithelium before (n = 6/7; two-sided Student’s t test) and on day 15 of AOM/DSS (n = 5/5; two-sided Stu-
dent’s t test). (G) Detection of aneuploidy by analysis of DNA content with propidium iodide in isolated colonic IECs (n = 3/3; one-sided Student’s t test; 
M1 = G0/G1; M2 = G2/S; M3 = aneuploid). (H) IHC on day 15 of the AOM/DSS model localizes increased p-Stat3 immunoreactivity to IECs (n = 4/4). Bars: 
(B) 2 mm; (E [top] and H) 50 µm; (E, bottom) 20 µm. (I) Western blot for p-Stat3, Stat3, p-Jak1, and Jak1 on colonic IEC scrapings on day 15 of the 
AOM/DSS model. Gapdh was used as a loading control. Data are representative of two independent experiments. Graphs show mean ± SEM. §, P = 0.1024; 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM Vol. 210, No. 10 
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e.g., inactivating somatic mutations in adenomatous polyposis 
coli (APC) are very common and appear early as a rate-limiting 
step in CRC pathogenesis (Kinzler and Vogelstein, 1996; 
Fearon, 2011; Cancer Genome Atlas Network, 2012) but late 
in CAC (Leedham et al., 2009). Germline mutations in APC 
also cause familial adenomatous polyposis. APC-associated 
CRC can be modeled in Apc mutant mice (Moser et al., 1990). 
Such a model has enabled the determination that ISCs are the 
cells of origin in CRC (Barker et al., 2009; Zhu et al., 2009; 
Schepers et al., 2012). The expansion of ISCs in Xbp1/(IEC) 
mice, and the desire to delineate the specific tumor-promoting 
role of Xbp1 deficiency specifically in IECs, prompted us to 
Epithelial Xbp1 suppresses tumor formation in Apcmin/+ mice
Inflammatory signaling is an important contributor to CAC 
but also to sporadic and familial CRC (Rakoff-Nahoum   
and Medzhitov, 2007; Lee et al., 2010), with overlapping and 
distinct inflammatory pathways being involved (Salcedo et al., 
2010). ER stress in various organs, including the liver, skeletal 
muscle, adipose tissue (Ozcan et al., 2004; Gregor et al., 2009; 
Kars et al., 2010), and intestinal crypts (Hodin et al., 2011),   
is associated with obesity, which is epidemiologically closely 
associated with increased cancer incidence, most notably 
CRC (Calle et al., 2003). CRC and CAC exhibit distinguishing 
features with regard to their molecular genetic underpinning; 
Figure 5.  Epithelial Xbp1 suppresses tumor burden in Apcmin mice. (A) Representative macroscopic pictures of the colon with rectal tumors in the 
indicated genotypes analyzed at age 15 wk (n = 13/10). Boxed areas are shown at higher magnification on the right. (B) Representative H&E-stained sec-
tions, with tumors highlighted by dotted lines (n = 13/10). (C) Quantification of tumor numbers per mouse along the intestinal tract (n = 13/10; two-
sided Student’s t test). (D) Peripheral blood count of the indicated genotypes at age 15 wk (n = 13/10; two-sided Student’s t test). (E) Ileal and colonic 
tumor counts in the indicated genotypes stratified by size of tumors (n = 13/10; two-sided Student’s t test). (F) Tumors from colons of Xbp1+/+(IEC);Apcmin 
and Xbp1/(IEC);Apcmin mice were microdissected, and mRNA expression of the indicated targets was analyzed by qPCR (n = 5/5; two-tailed Student’s  
t test). (G) Olfm4+ ISCs (red arrowheads; ISH) and lysozyme+ Paneth cells (black arrowheads; IHC) in the indicated genotypes (n = 4/4). Bars: (A) 5 mm; 
(B) 100 µm; (G) 5 µm. (H) Number of Olfm4+ ISCs per 100 crypts in Xbp1+/+(IEC);Apcmin and Xbp1/(IEC);Apcmin small intestines. The occasional presence of 
crypts with lysozyme+ mature Paneth cells among the vast majority of crypts with lysozyme Paneth cell remnants in Xbp1/(IEC);Apcmin mice allowed 
crypt-specific stratification of Olfm4+ cell enumeration in lysozyme+ and lysozyme crypts (n = 4/4; two-sided Student’s t test). Graphs show mean ± 
SEM. §, P = 0.0519; *, P < 0.05; **, P < 0.01; ***, P < 0.001.2050 Xbp1 controls intestinal tumorigenesis | Niederreiter et al.
Xbp1/(IEC);Apcmin genotype, ISC expansion was solely noted 
in crypts with Paneth cell remnants, whereas crypts with in-
tact lysozyme+ Paneth cells (in immediate vicinity to those 
without) exhibited ISC numbers indistinguishable from those 
found in the Xbp1+/+(IEC);Apcmin genotype (Fig. 5, G and H). 
These data suggest that expansion of ISCs is not merely a result 
of the surrounding proinflammatory milieu, which would simi-
larly affect the occasional crypts with intact lysozyme+ Paneth 
cells, but an IEC-inherent, Xbp1- and ER stress–dependent, 
crypt-autonomous process.
Tumor formation in Xbp1/(IEC);Apcmin mice  
is dependent on Ire1
Analogous to its role in ISC expansion under ER stress, we 
hypothesized that tumor formation in Xbp1/(IEC);Apcmin  
mice would be dependent on Ire1. Hence, Ern1/(IEC); 
Xbp1/(IEC);Apcmin mice would be predicted to be indistin-
guishable in tumor formation from Apcmin mice. We generated 
mice that harbored floxed alleles for both Xbp1 and Ern1 that 
were also hemizygous for Apcmin and compared littermates 
that expressed one allele of the Villin-Cre transgene with those 
that did not. We observed that deletion of Ern1 in the intestinal 
epithelium eliminated the increased tumorigenesis caused by 
Xbp1 deficiency in Apcmin mice. Specifically, as depicted in   
Fig. 6 (A–D), tumor numbers in Ern1/(IEC);Xbp1/(IEC);Apcmin 
mice were indeed no longer significantly different from   
Ern1+/+(IEC);Xbp1+/+(IEC);Apcmin mice, and even tended to be 
lower. These data indicate that increased tumor formation in 
Apcmin mice consequent to Xbp1 deletion is dependent on ER 
stress sensed by Ire1 and may, by inference, be related to the 
Ire1-dependent activation of ISCs.
DISCUSSION
We report here that epithelial injury resulting from ER stress 
is a potent activator of IEC regeneration and promotes intes-
tinal  tumorigenesis.  Hypomorphic  Xbp1  causes  ER  stress 
that is sensed by Ire1 and increases ISC numbers, whereas 
Stat3 signaling, independent of Ire1, increases the output of 
differentiated IECs. This organ-protective function, when 
investigate whether unresolved ER stress augments tumori-
genesis in this CRC model.
Xbp1/(IEC)  mice  crossed  onto  an  Apcmin  background 
(Xbp1/(IEC);Apcmin) developed twofold more tumors than 
their Xbp1+/+(IEC);Apcmin littermates (Fig. 5, A–C), along with 
lower blood hemoglobin levels reflecting intestinal blood loss 
(Fig. 5 D). Increased tumor numbers in Xbp1/(IEC);Apcmin 
mice were detected in the small intestine, but also the colon, 
where only few tumors typically develop in the Apcmin model 
(Fig. 5, C and E). Colonic tumors are notable because Xbp1 
deletion does not induce colonic, but only small intestinal   
inflammation (Kaser et al., 2008), suggesting that ER stress–
induced tumor promotion is independent of overt inflam-
mation  in  the  colon.  Nonetheless,  colonic  tumors  from 
Xbp1/(IEC);Apcmin mice exhibited increased Il6 and Il11 mRNA 
expression compared with those from Xbp1+/+(IEC);Apcmin litter-
mate controls (Fig. 5 F). Tumors in Xbp1-deficient mice ex-
hibited Xbp1 deletion, excluding outgrowth from Xbp1- 
sufficient IECs (not depicted). Together, these experiments 
demonstrate that Xbp1 suppresses the growth of spontane-
ously arising intestinal tumors.
ISC expansion is individually determined  
in each Xbp1-deficient crypt
The Xbp1/(IEC);Apcmin model serendipitously also afforded 
us the opportunity to study whether regulation of ISC num-
bers by Xbp1 was autonomously regulated within individual 
crypts or, alternatively, was a consequence of the inflamma-
tory milieu of the inflamed small intestinal mucosa. Although 
lysozyme staining was absent in the vast majority of Paneth 
cells (i.e., Paneth cell remnants) in Xbp1/(IEC) epithelia   
(Fig. 1 F; Kaser et al., 2008), the occasional (5%) occurrence of 
crypts with intact lysozyme+ Paneth cells in Xbp1/(IEC);Apcmin 
epithelia (which is presumably caused by inefficient Cre- 
mediated Xbp1 deletion and hence mosaicism or, alterna-
tively, caused by effective adaptation to ER stress despite Xbp1 
deletion) allowed us to quantify Olfm4+ ISCs separately   
in crypts without (i.e., Paneth cell remnants) and with (i.e., 
normal, mature Paneth cells) lysozyme expression. Within the 
Figure 6.  Increased tumor formation in 
Xbp1/(IEC);Apcmin mice is dependent on 
Ire1. (A) Representative macroscopic pic-
tures of colonic tumors of the indicated geno-
types analyzed at age 15 wk (n = 14/10). 
Boxed areas are shown at higher magnifica-
tion on the right. Bars, 5 mm. (B) Enumeration 
of tumors in the indicated genotypes at 15 wk 
of age. Mean tumor numbers ± SEM along 
the intestinal tract are shown (n = 14/10; 
two-sided Student’s t test). (C and D) Ileal 
(C) and colonic (D) tumor counts stratified by 
tumor size (n = 14/10; two-sided Student’s  
t test). Graphs show mean ± SEM.JEM Vol. 210, No. 10 
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Xbp1+/+(IEC) crypts may have a role as a trans-acting factor   
and deserves further exploration in vivo. Wnt11 has been 
shown to be expressed at elevated levels in patients with ul-
cerative colitis (You et al., 2008), gastric carcinoma cell lines, 
and primary CRC cells (Uysal-Onganer and Kypta, 2012), 
and it can induce the proliferation and transformation of the 
IEC6 line in vitro (Ouko et al., 2004). Analogous to the model 
proposed in this paper, Paneth cells have recently been re-
ported to sense calorie restriction (via mTORC1) and orches-
trate ISC expansion in trans (Yilmaz et al., 2012). However, 
because Vil-Cre recombines in all IEC types (including ISCs), 
another possibility is that the effects of Xbp1 deletion could 
also have yet-to-be-defined direct effects on ISCs themselves. 
However, ISCs express only minute levels of Xbp1 and do not 
exhibit evidence of Xbp1 splicing (Heijmans et al., 2013; 
Schwitalla et al., 2013) under basal conditions. Neither of 
these hypotheses are mutually exclusive.
Although expansion of ISCs in the setting of ER stress 
was mediated by Ire1, the increased turnover of Xbp1- 
deficient IECs was independent of Ire1, suggesting different 
underlying mechanisms for both aspects of this regenerative 
response. An analogous discordant regulation of ISC expan-
sion and proliferative output from transit-amplifying cells, and 
hence the engagement of separate mechanisms, has also been 
observed in the aforementioned study by Yilmaz et al. (2012), 
in which sensing of calorie restriction via mTORC1 in   
Paneth cells led to increased ISC numbers but decreased pro-
liferative output of differentiated epithelial cells. IEC-specific 
Stat3 is essential for epithelial restitution and wound healing 
upon injury, where it localizes with increased epithelial   
proliferation (Pickert et al., 2009). Indeed, Xbp1 deletion,   
independently of Ire1, leads to activation of Stat3 in the 
transit-amplifying zone. Consistent with this, pharmacologic 
blockade of Stat3 signaling abrogates heightened turnover of 
IECs in Xbp1/(IEC) mice. The secretion of the Stat3-activating 
cytokines IL-6 and IL-11 by Xbp1-silenced MODE-K cells 
suggests a feed forward loop instigated by ER-stressed IECs, 
which is relayed via Jak1. Il6 is a prototypical NF-B target 
gene (Vallabhapurapu and Karin, 2009;  Yu et al., 2009), and Il6 
and Il11 can be transactivated by Stat3 (Yu et al., 2009). Given 
our observations here, it might be speculated that increased 
NF-B activation as a consequence of pathological ER stress 
(Wu et al., 2004; Schröder and Kaufman, 2005) in the Xbp1-
deficient epithelium might be an inciting event that leads to 
excessive production of IL-6, which activates Stat3, which 
may further transactivate Stat3, Il6, and Il11. Indeed, pharma-
cologic blockade of NF-B signaling abrogated Stat3 Tyr-705 
phosphorylation in Xbp1/(IEC) epithelium.
Malignant cells are commonly exposed to hypoxia, nutri-
ent deprivation, and pH changes that impact protein folding 
(Ma and Hendershot, 2004; Hetz et al., 2011; Luo and Lee, 
2013). Human tumor cells indeed exhibit evidence of ER 
stress, and reduced capacity to elicit an UPR within malig-
nant cells results in decreased tumorigenesis in model systems 
(Ma and Hendershot, 2004; Bi et al., 2005; Fu et al., 2008; Luo 
and Lee, 2013). Xbp1 has been considered protumorigenic 
sustained, augments tumor formation in both an inflamma-
tory (i.e., CAC after DSS/AOM) and noninflammatory (i.e., 
CRC in Apcmin mice) context. Cytokines and other factors 
originating from the more prominent inflammatory infiltrate 
in Xbp1/(IEC) mice exposed to DSS (Kaser et al., 2008) will 
likely contribute to increased tumorigenesis in the AOM/
DSS CAC model (Kuraishy et al., 2011) through effects on   
the  Ire1-dependent  and  -independent  pathways  described 
here. However, it is clear that the hyperregenerative response 
observed in the setting of hypomorphic epithelial Xbp1 func-
tion is not only a consequence of increased inflammation   
as increases in colonic tumor formation were observed in 
Apcmin;Xbp1/(IEC) mice, which is not associated with appre-
ciable inflammation in this locale when Xbp1 is deficient 
(Kaser et al., 2008). Moreover, increased tumor formation   
in Xbp1-deficient Apcmin mice is dependent on Ire1, link-
ing ER stress sensing to increased intestinal tumorigenesis. 
This  relationship  has  important  ramifications  as  the  UPR   
integrates microbial, environmental, and inflammatory sig-
nals at the mucosal surface and highlights an unexpected 
tumor-suppressive role of Xbp1 that is associated with the   
intestinal epithelium.
The UPR transcription factor Xbp1 is critical for IEC 
homeostasis in that its reduced function causes pathological 
ER  stress  and  spontaneous  enteritis  in  the  small  intestine 
(Kaser et al., 2008). As shown here, sensing of unresolved ER 
stress by Ire1 and its consequent overactivation is centrally 
related to increased ISC numbers observed in the Xbp1- 
deficient epithelium. Moreover, Ire1 does not notably affect 
homeostatic ISC function, but is only engaged as part of the 
regenerative response consequent to pathological ER stress.   
It might be speculated that this could involve regulated Ire1-
dependent decay (RIDD) of mRNAs of as yet poorly defined 
proteins involved in restraining the ISC niche (e.g., Wnt or 
growth factor receptor antagonists or regulatory microRNAs 
[Upton et al., 2012]). RIDD is engaged upon pathological 
ER stress and results in endonucleolytic degradation of ER-
localized mRNAs (Han et al., 2009; Hollien et al., 2009).
Paneth cells secrete factors that support the proliferation 
of intermingled ISCs (Sato et al., 2011). Paneth cells are par-
ticularly susceptible to impairment in the UPR as Xbp1 dele-
tion in IECs results in loss of their characteristic secretory 
granules (resulting in Paneth cell remnants); however, Paneth 
cell remnants remain juxtaposed to ISCs (Kaser et al., 2008). 
The direct relationship between ISC expansion and the pres-
ence of Paneth cell remnants within discrete crypts observed 
in the Xbp1/(IEC);Apcmin genotype (Fig. 5 H) also implies 
that ISC expansion may be autonomously regulated within 
individual crypts. Xbp1 splicing (i.e., active Xbp1s) localizes to 
Paneth cells, transit-amplifying cells, and cells further up the 
crypt–villus axis, whereas ISCs do not express appreciable 
levels of Xbp1s (Heijmans et al., 2013; Schwitalla et al., 2013), 
raising the possibility that ER stress in Paneth cell rem-
nants  may  directly  promote  ISC  expansion  (Sato  et  al., 
2011). Increased expression of the Paneth cell–specific (Sato 
et al., 2011) transcript Wnt11 in Xbp1/(IEC) compared with 2052 Xbp1 controls intestinal tumorigenesis | Niederreiter et al.
MATERIALS AND METHODS
Mice. Xbp1fl/fl;VillinCre (Xbp1/(IEC)) mice have been described previously 
(Kaser  et  al.,  2008).  Ern1fl/fl;VillinCre,  Xbp1fl/fl;Ern1fl/fl;VillinCre,  Xbp1fl/fl; 
VillinCre;Apcmin, and Ern1fl/fl;Xbp1fl/fl;VillinCre;Apcmin mice were generated by 
intercrossing Xbp1/(IEC) mice with Apcmin (The Jackson Laboratory; Moser 
et al., 1990) and Ern1fl/fl mice (Iwawaki et al., 2009). All mice were housed 
under specific pathogen–free conditions at Innsbruck Medical University, the 
University of Cambridge, and Harvard Medical School. The mating strategy 
involved keeping the Cre and Apcmin alleles hemizygous so that nondeleted or 
non-Apcmin offspring was generated at 50% and hence could be used as litter-
mate controls. Mice were born at a Mendelian ratio, and mice on Apcmin 
background were regularly surveyed for rectal bleeding and general health 
status. Mouse protocols were approved by the relevant authorities, and all 
procedures were performed in accordance with institutional guidelines, using 
gender- and age-matched littermate controls whenever possible. S3I-201 
(EMD  Millipore),  SP600125  (Sigma-Aldrich),  and  BAY  11-7082  (EMD 
Millipore) were injected i.p. at 10 mg/kg, 30 mg/kg, and 5 mg/kg, respec-
tively, in 6–8-wk-old mice every other day for 14 d.
Antibodies. Antibodies directed to p-Stat3 (Tyr705; D3A7), Stat3 (79D7), 
p-Jak1 (Tyr1022/1023), Jak1 (6G4), p-Jak2 (Tyr1007/1008; C80C3), Jak2 
(D2E12),  p–NF-B  p65  (Ser536;  93H1),  NF-B  p65  (D14E12),  Gapdh 
(14C10), Ire1 (14C10; all Cell Signaling Technology), Ire1 (H-190, Santa 
Cruz Biotechnology, Inc.), p-Ire1 (Ser724; Abcam), anti-lysozyme (Dako), 
p53  (CM5; Vector  Laboratories),  DIG  (Roche),  PCNA  (PC10; Thermo 
Fisher Scientific), IL-6 (MP5-20F3), IL-11 (188520), IgG1 isotype control 
(43414), and IgG2A isotype control (54447; all R&D Systems) were used.
AOM/DSS model. 6-8-wk-old Xbp1/(IEC) and Xbp1+/+(IEC) mice were 
injected i.p. with 12.5 mg/kg AOM (Sigma-Aldrich). Colitis was induced   
by two cycles of 2.5% DSS (MP Biomedicals) in drinking water for 5 d,   
followed by a 16-d tap water period (Fig. 4 A; Greten et al., 2004). The final 
DSS cycle (2%) was administered for 4 d, followed by a 10-d tap water   
period. Tumor count and tumor area were determined at day 61 in paraffin-
embedded hematoxylin and eosin (H&E)–stained “Swiss rolls.” Serial sections 
every 200 µm were analyzed for tumor number and area using the section 
with the largest diameter for each individual tumor by Scion Image software 
(Scion Corporation).
Apcmin model. Longitudinally cut formalin-fixed intestines of 15-wk-old 
Xbp1fl/fl;VCre;Apcmin or Ern1fl/fl;Xbp1fl/fl;VCre;Apcmin mice were analyzed 
under a stereomicroscope (SZH-ILLD; Olympus) and categorized accord-
ing to their size (Lee et al., 2010), complemented by H&E sections of   
paraffin-embedded  Swiss  rolls  (Rakoff-Nahoum  and  Medzhitov,  2007). 
Complete blood count was performed using Vet abc plus+ (Scil animal care 
company GmbH).
MODE-K cell cultures. MODE-K IECs cultured in DMEM-10 were 
transduced with Xbp1-specific or control shRNA lentiviral vectors as de-
scribed previously (Kaser et al., 2008), and stable clones were established. 105 
cells were seeded in 6-well plates overnight and Jak1-3, Tyk2, or control 
siRNA  (Life Technologies)  transfected,  and  experiments  were  harvested   
68–72 h after transfection. Tunicamycin (Sigma-Aldrich) was added at 2 µg/ml 
and anti–IL-6/11 antibodies or isotype control antibodies at optimal concen-
trations of 2 µg/ml and 20 µg/ml, respectively, and IL-6 and IL-11 in super-
natants were measured by ELISA (BD and R&D Systems, respectively).
Crypt  isolation.  Crypt  isolation  was  performed  as  previously  reported 
(Muñoz et al., 2012). In brief, the small intestine was flushed with cold PBS 
and cut longitudinally. Subsequent to scraping on ice, which removed most 
villi, the intestine was cut into 5-mm pieces and incubated for 5 min in   
5 mM EDTA/PBS. Pieces were placed in 30 mM EDTA/PBS for 30 min, 
passed through a 100-µm cell strainer, and centrifuged, RNA was isolated 
from crypts, and RT-qPCR was performed as described below.
(Luo  and  Lee,  2013);  Xbp1-deficient  tumor  cells  exhibit   
impaired growth when xenografted into Scid mice (Romero-
Ramirez et al., 2004, 2009), and disruption of Ire1/Xbp1 
signaling may be exploited pharmacologically for the treat-
ment of multiple myeloma (Lee et al., 2003; Mimura et al., 2012). 
Our  data  imply  an  unexpected  tumor-preventive  role  of 
Xbp1 in the intestinal epithelium. In this rapidly renewing 
tissue that is constantly exposed to noxious stimuli that may 
impact protein folding, Xbp1 may not only assist in resolving 
ER stress but may thereby keep the regenerative response, in-
cluding stem cell activation, in check. However, overwhelming 
the remedial abilities of Xbp1 (e.g., through genetic hypofunc-
tion of Xbp1 or persistence of microbial or environmental 
ER stressors including those that inhibit Xbp1 function; 
Tashiro et al., 2007) may initiate a compensatory regenerative 
response, which is facilitative of neoplasias if persistent. In line 
with this, the architecture of ISCs in close proximity to Paneth 
cells is preserved in tumors (Schepers et al., 2012), which we 
speculate might result in a situation in which the increase in 
ISCs and proliferative output in Xbp1/(IEC) tumors may 
outcompete any potential survival disadvantage of differen-
tiated epithelial cells caused by Xbp1 deficiency.
Finally, the very mechanisms that appear critical for tumor 
initiation and promotion during CAC (NF-B, IL-6, and 
Stat3; Becker et al., 2004; Greten et al., 2004; Bollrath et al., 
2009; Grivennikov et al., 2009, 2010; Kuraishy et al., 2011) are 
engaged when Xbp1 function is relatively insufficient. In   
parallel, the Ire1-dependent expansion of the ISC compart-
ment increases the stochastic chance for genotoxic damage in 
these cells of origin of intestinal cancer (Barker et al., 2009; 
Zhu et al., 2009; Medema and Vermeulen, 2011; Schepers   
et al., 2012). Indeed, the Ire1 dependence of increased tu-
morigenesis in Xbp1/(IEC);Apcmin mice critically implies a fun-
damental role of ER stress sensing as a facilitator of CRC. 
Apart from integrating environmental, microbial, genetic, and 
inflammatory inputs that affect ER stress levels at the hostile 
intestinal surface, Ire1 itself might also be affected by so-
matic mutations in tumors. Indeed, it has ranked promi-
nently as carrying driver mutations in a large-scale survey of 
the human kinase-ome in diverse human tumors (Greenman 
et al., 2007).
In summary, this study demonstrates an unexpected role 
of Xbp1 in restraining the development of CAC and nonin-
flammation-associated CRC. These Xbp1-dependent effects 
mechanistically derive from a role for Xbp1 in regulating the 
activity of Ire1, which in turn determines the size of the 
ISC pool and its propensity to develop intestinal neoplasias 
when perturbed, and in restraining an IEC-intrinsic inflam-
matory response that is mediated by NF-B, IL-6, IL-11, and 
Stat3, which are directly involved in promoting IEC prolifer-
ation and expansion of the transit-amplifying compartment. 
Together, the unrestrained activity of the Ire1-regulated ISC 
compartment and Stat3-mediated hyperproliferation are cen-
tral to the development of colorectal neoplasia in the pres-
ence of hypomorphic Xbp1 function.JEM Vol. 210, No. 10 
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